GLP-1 companion nutrition formulation

PRODUCT DEVELOPMENT : GLP-1 COMPANION

The nutrition problem is real. The claims are the hard part.

The nutrition problem is real. The claims are the hard part.

People on GLP-1 therapies eat substantially less, and reduced intake creates genuine nutritional consequences: lean mass loss, protein inadequacy, micronutrient shortfall and digestive tolerance issues. The products that work in this category are smaller, nutrient-dense formats built around protein, fibre and overall nutritional adequacy, designed for people who are eating less rather than for a named therapy. There is a real product category here. There is also a claims boundary that most entrants cross without realising, and the regulatory consequence of crossing it is not a warning letter, it is a drug classification.

GLP-1 companion nutrition formulation

PRODUCT DEVELOPMENT : GLP-1 COMPANION

The nutrition problem is real. The claims are the hard part.

People on GLP-1 therapies eat substantially less, and reduced intake creates genuine nutritional consequences: lean mass loss, protein inadequacy, micronutrient shortfall and digestive tolerance issues. There is a real product category here. There is also a claims boundary that most entrants cross without realising, and the regulatory consequence of crossing it is not a warning letter, it is a drug classification.

Product development bench in a food science laboratory

THE BOUNDARY

Adjacent to a drug is not the same as about a drug.

Adjacent to a drug is not the same as about a drug.

Nutritional support and drug-related positioning require different assessments. We review the formula, format, intended use, and proposed claims together to establish the appropriate pathway in each target market.

WHAT THE CATEGORY ACTUALLY NEEDS

Four technical problems.

Four technical problems.

01

Lean mass support

Protein quantity, quality and leucine threshold at intakes well below normal, in a format someone with reduced appetite will actually finish.

02

Micronutrient sufficiency

Reduced intake compresses the margin on every micronutrient at once. Which ones matter, at what levels, and how they interact with reduced gastric emptying.

03

Digestive tolerance

Fibre type and load, osmotic behaviour, and formats that do not compound nausea or early satiety.

04

Hydration and electrolytes

Reduced intake reduces fluid and electrolyte intake alongside it. The concentration that works for an athlete is not the concentration that works here.

FORMAT ASSESSMENT

Different needs. Different product formats.

Different needs. Different product formats.

We start with the nutritional objective, then assess the format that can realistically deliver it. Serving size, taste, ingredient compatibility, stability, and regulatory positioning are developed together.

Protein-forward nutrition

Powders, sachets, and beverage concepts assessed for protein delivery, serving volume, taste, and texture.

Targeted micronutrient support

Capsules, powders, liquids, and chewables developed around a defined nutritional rationale and practical daily use.

Fiber and digestive-wellness concepts

Ingredient and format selection with attention to serving size, mixing behaviour, sensory experience, and tolerability.

Hydration formats

Drink mixes and liquid concepts assessed for intended use, dilution, electrolyte composition, and flavour.

These are potential development directions, not approved products or guaranteed capabilities across every format.

These are potential development directions, not approved products or guaranteed capabilities across every format.

THE SERVING

Designed around the serving, not just the ingredient list.

Designed around the serving, not just the ingredient list.

A formula must work beyond the specification sheet. We assess how the intended dose, format, and daily routine fit together before development moves forward.

Dose and volume

Dose and volume

What should each serving deliver, and how much product does that require?

Taste and texture

Taste and texture

Which flavour, sweetness, mouthfeel, and aftertaste profiles should prototypes explore?

Tolerability

Tolerability

Which ingredients, combinations, and serving instructions need closer assessment?

Practical use

Practical use

What mixing, measuring, storage, and serving frequency will the product require?

Stability and quality

Stability and quality

What testing is needed to establish shelf life and finished-product specifications?

WHAT WE DO

Formula and claim boundary together.

Category and white space assessment.

Formulation to the nutritional requirement rather than the marketing concept.

Format and sensory development for reduced appetite.

Claim boundary definition per market, stated as what can and cannot be said.

Substantiation mapping for the claims retained.

Label and pathway for Canada and the United States.

Review of consumer-facing copy, listing content and any healthcare professional material.

WHAT YOU RECEIVE

A clear development brief. A practical path forward.

A clear development brief. A practical path forward.

Whether you bring an early concept or an existing formula, we help identify what is supportable, what needs development, and what should change. Depending on the project scope, deliverables may include:

01

Product feasibility brief

Intended user, nutritional objective, proposed format, and key development risks.

02

Formulation rationale

Proposed ingredients, amounts, and supporting scientific rationale.

03

Claims and evidence matrix

Proposed wording, evidence gaps, and market-specific limitations.

04

Development and testing plan

Prototype priorities, specifications, and stability or specialist testing needs.

05

Market-entry roadmap

Classification assessment, documentation requirements, and next steps for the intended markets.

A NOTE ON POSITIONING

What we will not help you say.

What we will not help you say.

We do not develop products positioned as treating side effects, replacing medical care, enhancing a therapy, or as an alternative to one. That is not caution, it is the line between a supplement and a drug, and brands that cross it lose the product rather than the claim.

Bring the concept before the copy is written.

Bring the concept before the copy is written.

Send us the concept, the intended format and the markets. We will define the formula requirement and the claim boundary side by side.